233 related articles for article (PubMed ID: 11762360)
1. Epidemiology, clinical features and diagnosis of gastroenteropancreatic endocrine tumours.
Tomassetti P; Migliori M; Lalli S; Campana D; Tomassetti V; Corinaldesi R
Ann Oncol; 2001; 12 Suppl 2():S95-9. PubMed ID: 11762360
[TBL] [Abstract][Full Text] [Related]
2. Biochemical markers for gastroenteropancreatic neuroendocrine tumours (GEP-NETs).
Kanakis G; Kaltsas G
Best Pract Res Clin Gastroenterol; 2012 Dec; 26(6):791-802. PubMed ID: 23582919
[TBL] [Abstract][Full Text] [Related]
3. Tumor markers in neuroendocrine tumors.
Eriksson B; Oberg K; Stridsberg M
Digestion; 2000; 62 Suppl 1():33-8. PubMed ID: 10940685
[TBL] [Abstract][Full Text] [Related]
4. Tumour markers in neuroendocrine tumours.
Oberg K; Janson ET; Eriksson B
Ital J Gastroenterol Hepatol; 1999 Oct; 31 Suppl 2():S160-2. PubMed ID: 10604122
[TBL] [Abstract][Full Text] [Related]
5. Biochemistry of neuroendocrine tumours.
de Herder WW
Best Pract Res Clin Endocrinol Metab; 2007 Mar; 21(1):33-41. PubMed ID: 17382264
[TBL] [Abstract][Full Text] [Related]
6. Clinical significance of blood chromogranin A measurement in neuroendocrine tumours.
Seregni E; Ferrari L; Bajetta E; Martinetti A; Bombardieri E
Ann Oncol; 2001; 12 Suppl 2():S69-72. PubMed ID: 11762355
[TBL] [Abstract][Full Text] [Related]
7. Biochemical diagnosis of neuroendocrine GEP tumor.
Oberg K
Yale J Biol Med; 1997; 70(5-6):501-8. PubMed ID: 9825477
[TBL] [Abstract][Full Text] [Related]
8. [Surgical treatment of gastric, enteric, and pancreatic endocrine tumors Part 1. Treatment of primary endocrine tumors].
Kianmanesh R; O'toole D; Sauvanet A; Ruszniewski P; Belghiti J
J Chir (Paris); 2005; 142(3):132-49. PubMed ID: 16142076
[TBL] [Abstract][Full Text] [Related]
9. [Biology and imaging of neuroendocrine tumors].
Baudin E; Dromain C
Rev Prat; 2002 Feb; 52(3):268-73. PubMed ID: 11925716
[TBL] [Abstract][Full Text] [Related]
10. The Neuroendocrine Neoplasms of the Digestive Tract: Diagnosis, Treatment and Nutrition.
Pobłocki J; Jasińska A; Syrenicz A; Andrysiak-Mamos E; Szczuko M
Nutrients; 2020 May; 12(5):. PubMed ID: 32429294
[TBL] [Abstract][Full Text] [Related]
11. Diagnosis of non-Zollinger-Ellison syndrome, non-carcinoid syndrome, enteropancreatic neuroendocrine tumours.
Metz DC
Ital J Gastroenterol Hepatol; 1999 Oct; 31 Suppl 2():S153-9. PubMed ID: 10604121
[TBL] [Abstract][Full Text] [Related]
12. [Pancreatic polypeptide secreting endocrine pancreas tumor associated with multiple stomach and duodenal ulcers].
Mehring UM; Jäger HJ; Klöppel G; Hasse FM
Langenbecks Arch Chir; 1997; 382(3):134-7. PubMed ID: 9324611
[TBL] [Abstract][Full Text] [Related]
13. Radioimmunoassay in diagnosis, localization and treatment of endocrine tumours in gut and pancreas.
Rehfeld JF
Scand J Gastroenterol Suppl; 1979; 53():33-8. PubMed ID: 225784
[TBL] [Abstract][Full Text] [Related]
14. Three subtypes of gastric argyrophil carcinoid and the gastric neuroendocrine carcinoma: a clinicopathologic study.
Rindi G; Luinetti O; Cornaggia M; Capella C; Solcia E
Gastroenterology; 1993 Apr; 104(4):994-1006. PubMed ID: 7681798
[TBL] [Abstract][Full Text] [Related]
15. [Neuroendocrine tumors of the gastrointestinal tract].
Arnold C
Praxis (Bern 1994); 2007 Jan; 96(1-2):19-28. PubMed ID: 17256557
[TBL] [Abstract][Full Text] [Related]
16. Pancreatic endocrine tumors.
Oberg K
Semin Oncol; 2010 Dec; 37(6):594-618. PubMed ID: 21167379
[TBL] [Abstract][Full Text] [Related]
17. Biochemical Testing in Patients with Neuroendocrine Tumors.
Granberg D
Front Horm Res; 2015; 44():24-39. PubMed ID: 26303702
[TBL] [Abstract][Full Text] [Related]
18. A single-centre experience with octreotide in the treatment of different hypersecretory syndromes in patients with functional gastroenteropancreatic neuroendocrine tumors.
Berković MC; Altabas V; Herman D; Hrabar D; Goldoni V; Vizner B; Zjacić-Rotkvić V
Coll Antropol; 2007 Jun; 31(2):531-4. PubMed ID: 17847934
[TBL] [Abstract][Full Text] [Related]
19. Biomarkers in neuroendocrine neoplasms.
Zouli C; Zisimopoulou E; Chrisoulidou A
Hell J Nucl Med; 2023; 26 Suppl():44-48. PubMed ID: 37658563
[TBL] [Abstract][Full Text] [Related]
20. Detection of somatostatin receptor subtypes 2 and 5 by somatostatin receptor scintigraphy and immunohistochemistry: clinical implications in the diagnostic and therapeutic management of gastroenteropancreatic neuroendocrine tumors.
Sclafani F; Carnaghi C; Di Tommaso L; Rodari M; Destro A; Rimassa L; Giordano L; Chiti A; Roncalli M; Santoro A
Tumori; 2011; 97(5):620-8. PubMed ID: 22158494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
